Back to Screener

Technology

Nomura Research Institute, Ltd.(NURAF)

Live Price

Offline

$28.24

+0.00% today

1Y Change

-28.34%

Window

Jun 25, 2025 โ†’ Jun 17, 2026

Market Cap
$2.40T
Revenue Growth
+7.2%
EPS Growth
-83.4%
Dividend Yield
1.8%

Coverage: 250 bars ยท Jun 25, 2025 โ†’ Jun 17, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Nomura Research Institute, Ltd. (NURAF) is a Technology stock with a market cap of $2.40T and listed on OTC. The stock last traded around $28.24 and down 28.3% across the available one-year price window (Jun 25, 2025 โ†’ Jun 17, 2026). Baseline metrics include revenue growth of +7.2%, EPS growth of -83.4%, a dividend yield of 1.8%. What stands out right now is revenue +7.2%, EPS -83.4%, free cash flow +77.0% with operating margin 19.0% and ROIC 5.9%. The dividend is present but secondary, with a yield around 1.8%. Valuation already assumes a fairly strong business story at P/E 157.1 and price/sales 2.9. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines NURAF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Technology peers on this page.

Benchmark Edge

NURAF vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

NURAF

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

NURAF Max Drawdown

-46.77%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for NURAF and SPY.

Calendar-year return history is still loading or unavailable.

Financial profile

Nomura Research Institute, Ltd. (NURAF)

Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.

FY Revenue

$550.3B

-10.0% YoY

FY Net Income

$52.9B

-26.0% YoY

Free Cash Flow

$75.4B

+35.7% YoY

Revenue Growth

+7.2%

EPS Growth

-83.4%

Gross Margin

36.8%

Net Margin

1.9%

Income statement

JPY

Annual
Metric20252024202320222021
Revenue764.8B736.6B692.2B611.6B550.3B
Gross Profit275.3B261.0B239.8B185.8B180.9B
Operating Income134.9B120.4B111.8B106.2B80.7B
EBITDA188.9B167.1B159.1B150.1B123.5B
Net Income93.8B79.6B76.3B71.4B52.9B
EPS (Diluted)โ€”โ€”โ€”โ€”โ€”

Balance sheet

JPY

Point-in-time
Metric20252024202320222021
Cash & Equivalents168.6B173.9B129.3B153.2B102.5B
Total Assets928.5B922.8B838.2B656.5B528.1B
Total Liabilities490.5B519.8B435.8B323.3B246.0B
Shareholder Equity434.0B399.5B399.0B339.4B330.5B
Total Debt271.0B298.5B237.7B250.4B165.6B
Net Debt102.4B124.6B108.5B12.4B3.2B

Cash flow positioning

Latest Full Year

Operating Cash Flow

102.8B

+21.5% YoY

Capital Expenditures

27.4B

+5.6% YoY

Free Cash Flow

75.4B

+35.7% YoY

Key ratios

  • Gross Margin

    36.8%

  • Operating Margin

    19.0%

  • Net Margin

    1.9%

  • ROE

    3.3%

  • Debt / Equity

    0.54x

Next Step

Turn financials into a decision

Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.